Rosiglitazone
Back to searchMolecule Structure
Scientific Name
Rosiglitazone
Description of the Drug
Rosiglitazone is a thiazolidinedione indicated as an adjunct to diet and exercise to maintain glycemic control in type 2 diabetes.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00412
http://www.drugbank.ca/drugs/DB00412
Brand Name(s)
Avandia
Company Owner(s)
Teva Pharmaceuticals Usa Inc, Ani Pharmaceuticals Inc, Teva Pharmaceuticals Usa, Sb Pharmco Puerto Rico Inc, Woodward Pharma Services Llc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Peroxisome proliferator-activated receptor gamma | SINGLE PROTEIN | AGONIST | CHEMBL235 |
Clinical Trial(s)
Unichem Links
Atlas | rosiglitazone | |||
SureChEMBL | SCHEMBL5169 | |||
PharmGKB | PA451283 | |||
Human Metabolome Database | HMDB0005031 | |||
DrugBank | DB00412 | |||
PubChem: Thomson Pharma | 14876617 | |||
PubChem | 77999 | |||
Mcule | MCULE-8293284864 | |||
LINCS | LSM-1949 | |||
Nikkaji | J620.770G | |||
BindingDB | 50030474 | |||
EPA CompTox Dashboard | DTXSID7037131 | |||
DrugCentral | 2405 | |||
Brenda | 83445 | 3404 | ||
ChemicalBook | CB7133275 | |||
Guide to Pharmacology | 1056 | |||
rxnorm | AVANDIA | ROSIGLITAZONE | AVANDAMET | ROSIGLITAZONE MALEATE |
PubChem: Drugs of the Future | 50086904 | |||
ChEBI | 50122 |